AVR 0.25% $20.17 anteris technologies ltd

No negatives from here only positives.

  1. 86 Posts.
    With credentials like this one cannot be as far to say that Admedus are working with a morsern day Einstein in the eyes of the medical institutions and thousands of lives saved here is a basic excerpt from his .edu page:

    "Professor Frazer holds research funding from several Australian and US funding bodies. He is a director of a biotechnology start-up company, Coridon, with an interest in optimising and targeting polynucleotide vaccine protein expression. He is president of Cancer Council Australia, and advises the World Health Organisation and the Bill and Melissa Gates Foundation on papillomavirus vaccines. He won the 2005 CSIRO Eureka Prize for Leadership in Science, the Australian of the Year in 2006, and the Prime Minister's Prize for Science in 2008. Professor Frazer teaches immunology to undergraduate and graduate students of The University."

    Association to the WHO while advising such large scale corporate bodie(s) means that Mr. Frazer is in a light unlike no other as to advise these health orientated organisations about the devistating effects of HPV. While combating viruses is a tricky accomplishment and no doubt a remarkable one at that there are often draw backs and serious misgivings associated with these remarkabley unique medical advancement. While AHZ continues to be a viable market shaker in the areas of cardiovascular repair and advancement of treatments there appears to be an ever growing and looming association to organisations that have questionable practices and outcomes that are mostly unwanted.

    For example currently in India there are questions being raised as to the effectiveness of the vaccines administered to young girls.

    "Months later, many girls started falling ill and by 2010 five of them died. Two more deaths were reported from Vadodara, Gujarat, where an estimated 14,000 children studying in schools meant for tribal children were also vaccinated with another brand of HPV vaccine, Cervarix, manufactured by GSK. Earlier in the week, the Associated Press reported that scores of teenaged girls were hospitalised in a small town in northern Colombia with symptoms that parents suspect could be an adverse reaction to Gardasil."

    Mr.Frazer has association to the Gardasil as he was the lead researcher working for Merck as to produce key research for the legitmatcy and efficacy.

    "The CDC recommends the Gardasil vaccine, made by Merck Pharmaceuticals, for all females between 9 and 26 years to protect against HPV. Furthermore, the CDC says Gardasil is licensed, safe, and effective for males ages 9 through 26 years.

    The facts appear to contradict the FDA’s safety statements. The adverse reaction reports detail 26 new deaths reported between September 1, 2010 and September 15, 2011 as well as incidents of seizures, paralysis, blindness, pancreatitis, speech problems, short term memory loss and Guillain-Barré Syndrome. The documents come from the FDA’s Vaccine Adverse Event Reporting System (VAERS) which is used by the FDA to monitor the safety of vaccines."

    I just report facts.

    http://www.washingtontimes.com/news/2014/dec/31/us-court-pays-6-million-gardasil-victims/?page=all

    http://articles.economictimes.india..._1_hpv-vaccine-cervarix-human-papilloma-virus

    http://researchers.uq.edu.au/researcher/228
    • This message has been removed from public view. on 13/09/15 22:43because of (Spamming)
      Comments:27 posts on a negative theme in the one day is spamming ... Please give it a rest ... PD
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$20.17
Change
-0.050(0.25%)
Mkt cap ! $387.7M
Open High Low Value Volume
$20.20 $20.50 $20.00 $71.28K 3.532K

Buyers (Bids)

No. Vol. Price($)
1 776 $20.17
 

Sellers (Offers)

Price($) Vol. No.
$20.18 1200 1
View Market Depth
Last trade - 16.10pm 16/05/2024 (20 minute delay) ?
Last
$20.16
  Change
-0.050 ( 0.69 %)
Open High Low Volume
$20.17 $20.17 $20.09 129
Last updated 15.56pm 16/05/2024 ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.